Scholars@Duke

Predicting the risk of neutropenic complications and reduced dose intensity in patients with malignant lymphoma: Results from a prospective study.

Publication ,  Conference
Dale, DC; Crawford, J; Wolff, DA; Poniewierski, MS; Culakova, E; Lyman, GH
Published in: BLOOD
2004

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

BLOOD

ISSN

0006-4971

Publication Date

2004

Volume

104

Issue

11

Start / End Page

234B / 234B

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dale, D. C., Crawford, J., Wolff, D. A., Poniewierski, M. S., Culakova, E., & Lyman, G. H. (2004). Predicting the risk of neutropenic complications and reduced dose intensity in patients with malignant lymphoma: Results from a prospective study. In BLOOD (Vol. 104, pp. 234B-234B).
Dale, D. C., J. Crawford, D. A. Wolff, M. S. Poniewierski, E. Culakova, and G. H. Lyman. “Predicting the risk of neutropenic complications and reduced dose intensity in patients with malignant lymphoma: Results from a prospective study.” In BLOOD, 104:234B-234B, 2004.
Dale DC, Crawford J, Wolff DA, Poniewierski MS, Culakova E, Lyman GH. Predicting the risk of neutropenic complications and reduced dose intensity in patients with malignant lymphoma: Results from a prospective study. In: BLOOD. 2004. p. 234B-234B.

Published In

BLOOD

ISSN

0006-4971

Publication Date

2004

Volume

104

Issue

11

Start / End Page

234B / 234B

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology